Despite buzz around delta-8 THC, cannabinoid cultivation dominated by CBD, CBG

The entire cannabis industry is buzzing about delta-8 THC and other cannabinoids found rarely in the plant but gaining favor among growers and consumers.

Indeed, there has been a noticeable shift toward so-called novel cannabinoids among hemp producers surveyed by Hemp Industry Daily.

But CBD still rules the roost.

Cannabidiol, by far, continues to be the cannabinoid most growers strive to produce.

But one of the lesser-known cannabinoids, CBG, is gaining prominence. In 2019, 19% of hemp grown for cannabinoid extraction was for CBG; in 2020, that number grew to 43%. The percentage of hemp grown for CBD dropped from 96% in 2019 to 80% in 2020.

The shift likely stems in part from research and public interest in the novel cannabinoids, even though CBD is still the most profitable cannabinoid in the hemp market.

Hemp cultivated for CBN remained nearly the same from 2019 to 2020, at 10% and 12% respectively.

About 3% of growers were cultivating hemp for delta-8 THC, a category that has gained traction over the past year.

Hemp processors have been buying up excess flower and distillate on the market to make delta-8 THC, an edible and smokable extract that has become popular among consumers.

The market for delta-8 THC has helped both growers and extractors keep their doors open as the industry struggles with low wholesale prices due to an oversupply of hemp on the market and regulatory uncertainty, which have caused a bottleneck for CBD brands.

In August 2020, the U.S. Drug Enforcement Administration published an interim final rule that hemp industry opponents argue would make certain extracts, such as delta-8 THC, a Schedule 1 controlled substance.

However, the product’s legality may depend on whether it is made synthetically or derived organically.

The Hemp Industries Association and a South Carolina CBD manufacturer currently have a lawsuit pending over their interpretation of the DEA rule.

Read more about the race to find stable THC-V genetics here.

More exclusive intelligence about the hemp industry is available in the Hemp & CBD Industry Factbook 2021 Edition. It’s on sale here.

4 comments on “Despite buzz around delta-8 THC, cannabinoid cultivation dominated by CBD, CBG
  1. Greg Kinsky on

    Thank you for writing and posting this most important of posts if people are to fully understand where the legal help industry is heading. CBD has been the darling of the hemp derived cannabinoids. IMHO, once people realize the effects of Delta 8 THC, I truly believe there is going to be a huge market for it. I know of many people who purchase CBD in the hopes it will elicit some “feeling”, when in fact it has no psychoactive molecules. Delta 8 THC is chock full of psychoactives, and I highly urge any consumer of this product to please keep informed as to the legality of Delta 8 THC. I’m sure we all know the drug warriors in our government that wouldn’t skip a beat in making it illegal, thus destroying a market for Delta 8 THC, which is even safer than Delta 9 THC, which is already by its own right in being one of the safest molecules known to humanity!

    Reply
  2. C on

    Delta-8 in meaningful qualities is created from CBD. So it makes sense more CBD is being grown to then be used by companies to create Delta-8

    Reply
Leave a Reply

Your email address will not be published. Required fields are marked *